Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy
Part of paid clinical trials in Indianapolis, Indiana.
- Sponsor
- Indiana University
- Study ID
- NCT06996951
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Chronic Rhinosinusitis (CRS)
- Cystic Fibrosis (CF)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- STOP NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID — OTHERPATIENT WILL STOP USING NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID
- CONTINUE NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID — DRUGPATIENT WILL CONTINUE USING NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID
Study Details
The investigators are doing this study to discover if it is appropriate for people with Cystic Fibrosis (CF) on highly effective modulator therapy (HEMT) to stop using certain standard Sino nasal therapies such as high-volume nasal saline irrigations, topical nasal steroids, and topical nasal antibiotics. They are also going to study the fluid inside the nose to see if there are changes when stopping these therapies. Right now, they are not sure if it is suggested to stop these treatments when patients begin highly effective modulator therapy (HEMT)
Key Dates
- Start date
- Jul 2, 2025
- Status verified
- Dec 2025
- Primary completion
- Jul 31, 2026
- Completion
- Jul 31, 2026
Study Design
- Enrollment
- 64 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: CONTINUE TOPICAL STEROID NASAL IRRIGATIONPARTICIPANTS WILL CONTINUE THEIR NASAL TREATMENT WHICH WAS ALREADY PRESCRIBED BY THEIR PHYSICIAN
- Experimental: STOP TOPICAL NASAL TREATMENTPARTICIPANTS IN THIS ARM WILL BE ASKED TO STOP THEIR NASAL TREATMENT
Primary Outcome Measure
Change in Lund Kennedy Score [ Time Frame: Baseline, 12 weeks ]
Central Contacts
- Elisa Illing, MD317-944-6467
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Indiana University Health | Indianapolis | Indiana | 46202 | Elisa A Illing (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Indianapolis, IN
By research site
Related Studies
- CGM Dynamic Index for Predicting Prediabetes in Cystic FibrosisRecruiting · Indiana University · Indianapolis, Indiana
- TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of AgeRecruiting · State University of New York at Buffalo · Orange, California
- Lung Disease and Its Affect on the Work of White Blood Cells in the LungsRecruiting · University of Florida · Gainesville, Florida
- Kidney Function in People With Cystic Fibrosis in the Era of HEMTRecruiting · University of Virginia · Birmingham, Alabama